AI and smartphone videos could help parents spot seizures in newborns
NCT ID NCT07695623
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study aims to develop a machine learning tool that can predict which newborns are at high risk of having more seizures after leaving the hospital. Researchers will also create a mobile video education program for mothers of high-risk infants, teaching them how to recognize seizures, give emergency care, and manage medications. The study will test whether this education improves mothers' knowledge and reduces their anxiety compared to standard discharge instructions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mobile Video-Supported Education
- What this could lead to
- If successful, this approach could help identify infants at highest risk of seizure recurrence and provide parents with better tools to manage their baby's condition at home.
- What could go wrong
- This is a small, early-stage study (60 participants) focused on knowledge and anxiety, not on preventing seizures directly. The machine learning model may not be accurate enough for wider use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The infant is classified as high risk according to the machine learning-based risk prediction model developed in the first phase of the study. * The infant is planned to be discharged home from the Neonatal Intensive Care Unit of Başakşehir Çam and Sakura City Hospital. * The mother is 18 years of age or older. * The mother is the primary caregiver responsible for the infant's care. * The mother is able to read, write, and communicate in Turkish. * The mother has access to a smartphone and active internet connection, either mobile data or Wi-Fi. * The mother is able to use a smartphone and basic communication applications such as WhatsApp. * The mother voluntarily agrees to participate in the study and signs the informed consent form. Exclusion Criteria: * The infant is transferred to another center before completion of the study process or during the discharge period. * The infant dies during the study period. * The mother has a diagnosed cognitive or psychiatric condition that may prevent her from understanding the educational materials or managing the study process. * The mother has a visual or hearing impairment that may prevent her from following the video content. * Significant connection problems occur during the qualitative interview process that prevent completion of the interview. * The mother is unable to access or complete the mobile video education within the first 72 hours after discharge due to technical reasons. * The mother wishes to withdraw from the study at any stage.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Seizure recurrence are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.